INTRODUCTION
Hospital-acquired (HA) infections are an increasing global problem. Methicillin-resistant Staphylococcus aureus (MRSA) and glycopeptide-resistant Enterocococus (GRE) are multi-drug resistant organisms and are particularly frequent causes of HA infections that often prove difficult and expensive to treat. Major sources of MRSA and GRE causing infections are either the patients' own flora (endogenous) or acquired from another person (cross-infection) or from substances recently contaminated by a human source (environmental infection). Active surveillance cultures of patients for carriage of MRSA and GRE facilitate an early contact isolation (and even treatment), thus preventing spread in the hospital and reducing costs (42) . However, time to result with conventional cultures is 2-3 days, which allows these organisms a sizeable time window for potential spread prior to institution of contact precautions. Recently, several 'rapid' diagnostic tests have been introduced that would be very beneficial in decreasing the time to detection, therefore reducing the risk of nosocomial transmission and infections, especially in high-risk patients. This review discusses the current state-of-the-art on rapid and direct detection methods for MRSA and GRE from patient material and hopes to facilitate the infectious disease specialist or microbiologist in choosing an appropriate diagnostic test.
MRSA
Shortly after the introduction of methicillin into clinical use, the occurrence of MRSA began increasing steadily in hospitals and in nursing homes. MRSA now constitute 20%-55% of clinical isolates in Europe and USA (1) . Moreover, MRSA strains expressing heterogeneous resistance (a predominantly low-level resistant population co-existing with a small proportion of highly resistant cells) are often mistaken for MSSA by conventional culture and represent a hidden reservoir in hospitals [reviewed in (3) ]. Methicillin resistance in S. aureus is primarily mediated by the mecA gene that codes for the modified penicillin-binding protein 2a (PBP2a). MecA expression can be constitutive or inducible. MecA is carried on a mobile genetic element, the intrinsic. Of these, vanA is the most prevalent and is predominantly found in E. faecium and E. faecalis, the enterococcal species responsible for most infections in humans. Both vanA and vanB are inducible; vanA codes for high-level resistance to both vancomycin and teicoplanin, and vanB for variable levels of resistance to only vancomycin. VanC-harboring enterococci are low-level resistant to vancomycin and rarely cause human infections. The vanD, E, and G gene clusters are relatively uncommon; vanD is associated with variable levels of resistance to both vancomycin and teicoplanin, while vanE and vanG are characterized by low level resistance to vancomycin (9) .
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'RAPID' CULTURE BASED DETECTION METHODS
The general perception of culture based methods as being slow and laborious is rapidly undergoing a change with the introduction of the chromogenic agars, some of which can efficiently produce results within 24 hrs and without the added setup, expertise, and costs required for molecular tests. An ideal chromogenic medium allows a definitive identification of microorganisms directly from the primary isolation plate, eliminating further subcultures and biochemical confirmatory tests. Detection depends on the incorporated colorless chromogenic substrate that is designed to mimic a metabolic substrate and is cleaved by the targeted bacterial enzyme (selectivity also depends largely on the incorporated antibiotics). Once cleaved, the chromogen becomes both insoluble and colored, and builds up within the bacterial cell, allowing an easy differentiation of the organism possessing the enzyme based on colony color. Other factors influencing the medium's performance include the ability to support the growth of bacterium (especially with small inocula), the effective inhibition of the competing bacterial flora (dependent on the type and concentration of antimicrobial compounds incorporated), user friendliness (ease of colored colony differentiation), and optimal culture sites.
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on October 22, 2017 by guest http://jcm.asm.org/ Downloaded from 6 of cefoxitin than oxacillin, possibly due to an enhanced induction of PBP2a by cefoxitin (34) . Moreover, induction with oxacillin requires an extended period for full expression. Hence, oxacillin-containing media achieve sufficiently high sensitivities only after 48 hrs of incubation (2, 32) . Finally, inhibition of chromogen activity is also lower with cefoxitin than with oxacillin (32).
Analytical sensitivity, specificity, and influence of prolonged incubation time and enrichment
The currently available chromogenic media for MRSA detection show almost uniformly high specificities after 24 hrs incubation, although sensitivities tend to vary widely both between media and studies (2, 7, 26, 30, 38, 39) . Prolonging incubation time to 48 hrs can improve sensitivities however, specificities are adversely affected, necessitating confirmatory tests before reporting MRSA.
Studies investigating ChromID and MRSA Select generally corroborate the manufacturers' claims that after 24 hrs incubation characteristically colored colonies can be reported as MRSA without any need for confirmatory tests (2, 26, 30, 39) . However, a few studies report problems with false-positive colonies on these media and recommend a quick confirmatory test at 24 hrs (gram stain, latex agglutination) (7, 26, 38) . False-positive colonies on ChromID are mainly coagulase-negative staphylococci (CoNS), Enterobacter, and Stenotrophomonas maltophilia (also an α-glucosidase producer) (7). Gram-negative bacteria are also not completely inhibited on ChromID due to an insufficient cefoxitin concentration (4 mg/L), although these appear as colorless colonies and do not hamper MRSA detection (7) . On MRSA Select, enterococci also grow as colorless colonies and do not hinder MRSA detection, although false-positive pink-mauve colonies of enterococci or diphtheroids, and rarely, Enterobacteriaceae or CoNS have also been observed (26, 38) .
However on CHROMagar, enterococci appear as large, dark blue colonies due to which the smaller, pink MRSA colonies, especially when present in smaller numbers, might be obscured or completely missed (38) .
Frequency of false-positive colonies with ORSAB is high (31.6%), and is probably related to the low oxacillin A C C E P T E D 7 concentrations in this medium (2 mg/L) (40) . Coupled with a long latency period for oxacillin induction, this medium requires 48 hrs incubation and a coagulase test to achieve higher specificity and sensitivity (2).
Compernolle et al. compared ChromID, CHROMagar and ORSAB, and found CHROMagar to be the most sensitive (67%) after 24 hrs incubation although at 48 hrs, ChromID and ORSAB showed higher sensitivities (77%) (7) . Specificities of both ChromID (98%, 24 hrs; 94%, 48 hrs) and CHROMagar (98%, 24 hrs and 90%, 48 hrs) were high and superior to those of ORSAB (92%, 24 hrs; 83%, 48 hrs) (7) . Positive results on ChromID and CHROMagar after 24 hrs could be reported without additional testing. However after 48 hrs, confirmatory tests are necessary and ChromID's superior specificity and sensitivity resulted in a lesser workload compared to the other two media (7) . Also in another study, ChromID not only performed better than CHROMagar and ORSAB, but the former medium's sensitivity (80%) after 22-24 hrs incubation was superior to that of both CHROMagar (72%) and ORSAB (78%) incubated for 48 hrs (32) . Van Hal et al. also found sensitivities of ChromID to be higher than those of CHROMagar and MRSA Select. However, the 71% and 82% sensitivities of ChromID at 24 and 48 hrs, respectively, meant that approximately 18%-29% of MRSA-colonized patients would have been missed if this medium was utilized as a MRSA screening assay (39) . The high specificities of all three media (95%-99%) reiterated that confirmatory testing would not be necessary at 24 hrs (39). Cherkaoui et al. showed comparable sensitivities (76%-77%) and specificities (96%-97%) and a good colorimetric discrimination at 24 hrs on ChromID and MRSA Select, and both outperformed ORSAB partly due to the substitution of oxacillin with a cephamycin in the former two media (6) . At 48 hrs, sensitivities for both media increased to 90%-91%, and specificity of ChromID remained high at 95%, while that of MRSA Select decreased to 79% (6) . Another study compared ChromID and CHOMagar to the newly introduced Denim Blue agar (18) . The latter medium showed higher sensitivities and comparable specificities (90%; 96%) to CHROMagar (70%; 99.1%), and ChromID (60%; 99.3%) at 24 hrs. However at 48 hrs, there was a large increase in false-positive colonies on Denim Blue agar, and specificity of this medium decreased to followed by CHROMagar (59%), ChromID (51%) and ORSAB (47%), while at 42 hrs, sensitivity of ChromID was maximum (82%) (30) . Specificity for all four media was close to 100% at 24 hrs, and in contrast to most studies that observe a decrease in specificity on prolonged incubation, specificities remained 97%-98% at 42 hrs (30) . Prolonging incubation times to 42-48 hrs undoubtedly provides an improved sensitivity and yield, however, its overall utility remains debatable. Studies on MRSA Select show that the majority of the MRSA isolates (96%-99.8%) can be correctly detected after 18-24 hrs incubation without any requirement for confirmatory testing (2, 26) . Furthermore, sensitivities achieved in real practice might be even higher than those observed by these studies. Unlike analytical studies that inoculate test media using either a swab suspension in sterile saline or randomly inoculate a single swab on several media plates, in real practice, a single swab is inoculated onto one medium plate, delivering a much larger inoculum. Effect of inoculum size on the performance of CHROMagar, ChromID, and ORSAB was studied by Perry et al. using pure MRSA strains (32) . With a large inoculum (10,000 cfus) and 24 hrs incubation, CHROMagar could support the growth of all 37 MRSA strains, and ChromID and ORSAB of 35 strains. With a smaller inoculum (100 cfus), 35, 34, and 30 strains could be identified as MRSA on CHROMagar, ChromID and ORSAB, respectively (32) .
A C C E P T E D
The advantages of sample pre-enrichment versus direct plating were studied by Nahimana et al. who showed a substantial increase in sensitivity of ChromID, ORSAB, CHROMagar and MRSA Select following enrichment (30) . However, Cherkaoui et al. found that enrichment broth only marginally improved screening sensitivities for ChromID, ORSAB, and MRSA Select and the additional reporting delay imposed by its use revealed it to be of questionable benefit (6). In our hands, a strategy of a direct inoculation of surveillance samples on MRSA Select combined with an overnight enrichment provided the best balance between rapid results and increased sensitivities (20) . The direct inoculation allowed detection of 68% of the MRSA after 24 hrs and the
on October 22, 2017 by guest http://jcm.asm.org/ Downloaded from false negative results could be resolved by plating the enrichment broths, resulting in an almost 30% increase in sensitivity (20) .
Effect of sampling site
The anterior nares are the predominant site of MRSA carriage and expectedly, all chromogenic media perform best in detecting MRSA from nasal swabs. Sensitivities for MRSA detection from non-nasal samples decrease either due to a larger amount of competing flora or lower levels of MRSA colonization at these anatomical sites. However, 2.6% to 26.9% of MRSA-colonized patients show exclusive groin, rectal or perianal carriage and would be overlooked on nasal screening, which emphasizes the importance of screening non-nasal sites for MRSA carriage (4, 33, 44) . Van Hal et al. compared the performance of ChromID, MRSA Select, and CHROMagar using nose, groin and axilla swabs (39) . Combined sensitivities for all swabs and for axilla/ groin swabs were higher for ChromID (71%, 68%, respectively) than MRSA Select (64%, 52%) or CHROMagar (63%, 40%). However, sensitivities for MRSA detection from nasal swabs were higher for CHROMagar (75%) than ChromID (72%) or MRSA Select (68%) (39). Perry et al. evaluated ChromID, CHROMagar, and ORSAB for detection from nasal, perineal, and throat swabs and found ChromID's performance to be superior to the two other media (32). Nahimana et al. used nose, throat, perineum and other (wounds, urine) sample types to compare ChromID, CHROMagar, MRSA Select, and ORSAB and showed higher sensitivities for MRSA Select for each specimen type (nose, 79%; throat, 50%, others, 77%) except perineal swabs, for which the sensitivity was similar to that of ChromID and CHROMagar (≈ 60%) (30).
Time to detection
The time to detection is calculated from the time of inoculation of the sample to the confirmation of the presence of the relevant microorganism, also including tests recommended by the manufacturers. Time to detection for direct cultures was found to be minimum for MRSA Select (1.35 days) followed by ChromID (1.65 days), CHROMagar (1.72 days), and ORSAB (2.31 days). Also after enrichment, ChromID (2 days) performed better than CHROMagar (2.25 days) and ORSAB (3 days) (MRSA Select was not evaluated post-
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Cost effectiveness
Chromogenic media are expensive and this presents a major obstacle for their use in routine practice, as prices could be ~ 2 to 13 times higher than those of conventional media. However, a cost-effectiveness analysis should also take into account the number of subcultures, additional tests/reagents and technologist's time required to arrive at a definitive diagnosis.
A comparison of MRSA Select and mannitol-salt agar with 8 µg/ml cefoxitin (MSFOX) found the costs incurred to be nearly equivalent for both media ($9,758 versus $9,106 Canadian, respectively) because of the greater number of suspicious colonies growing on MSFOX which required subculture and additional testing to exclude the presence of MRSA. In addition, examination and processing of most chromogenic media (MRSA Select and ChromID) requires less technologist's time, which improves work flow efficiency in the laboratory (6, 26) .
A novel culture-based assay for MRSA detection
That culture-based assays are no longer limited to a macroscopic identification of bacterial colonies is best exemplified by the new Baclite Rapid MRSA test (3M Healthcare, Berkshire, UK). This assay detects ciprofloxacin-resistant MRSA strains by measuring adenylate kinase (AK) activity using bioluminescence. A total assay time of 5 hrs combines AK detection with selective broth enrichment, magnetic microparticle extraction and selective lysis of S. aureus to add target organism specificity. An initial study on nasal swabs has shown promising results (90.4% sensitivity, 95.7% specificity, and 98.7% NPV) (22) . The Baclite test requires a relatively low level of expertise and material costs are approximately USD 9.5-12 per test, which is higher than a conventional culture-based method but much lower than most commercial molecular tests. While
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further evaluation is awaited, a very evident drawback of this assay is the likelihood of missing CA-MRSA as well as the few HA-MRSA strains that are sensitive to ciprofloxacin. (Table 2) Development of chromogenic media for GRE has not been as rapid as for MRSA and till very recently, the most effective selective medium available for screening of GRE was bile esculin azide agar supplemented with 6-8 µg/ml of vancomycin (BEAV or Enterococcosel agar) (BD Diagnostics). Recent advances in elucidation of highly specific chromogenic substrates with sufficient sensitivity to identify GRE have led to the development of ChromID VRE (bioMérieux) and CHROMagar GRE (BD Diagnostics), however being rather new on the market, these media have not been extensively evaluated as yet. ChromID incorporates chromogens targeted by enzymes specific for E. faecium or E. faecalis, and their degradation distinguishes the two species as purple and blue-green colonies, respectively. CHROMagar GRE has been developed for the specific detection of GRE with the vanA and vanB genotypes, while the vanC genotype is inhibited.
Chromogenic media for GRE
The sensitivities for GRE detection from stool samples are similar for Chrom ID and BEAV/Enterococcosel agar using direct inoculation or enrichment (24) (A. Kuch, E. Stefaniuk, T. Ozorowski, W. Hryniewicz, submitted for publication). Although a major advantage with ChromID is that dual colonization with E.
faecalis and E. faecium is easily distinguishable; sensitivities for species level identification are 85.4% and 90.0% at 24 hrs and 87.8% and 90.0% at 48 hrs for E. faecium and E. faecalis, respectively (24). Specificities for both media are 100% at 24 hrs, and are sustained at 48 hrs for ChromID, however drop to 72% for BEAV (24) . An adequate suppression of the abundant stool flora is a major concern while developing media for GRE.
On ChromID, majority of the breakthrough growth is observed in the first quadrant of inoculation, probably because an excessive inoculum overwhelms the vancomycin in the medium, while on BEAV, contaminants are found in all quadrants. Diluting samples in sterile saline prior to plating can help circumvent this problem (23) . (23) . Contaminants on ChromID are frequently colorless and are not likely to be interpreted incorrectly (24) . Incubation of ChromID beyond 24 hrs does not seem to provide any improvement in sensitivity and also reduces the specificity due to breakthrough growth of normal glycopeptide-resistant flora like Candida spp (23) . Studies show that for the same response delay, reading ChromID plates after 24 hrs of incubation with enrichment provides a better performance than reading after 48 hrs of incubation and a direct inoculation (12) (A. Kuch, E. Stefaniuk, T. Ozorowski, W. Hryniewicz, submitted for publication). Use of an enrichment broth prior to plating does ensure a 100% detection rate of GRE (12), although the significance of increased sensitivity for the management of outbreaks has been questioned (8) . A 24 hrs incubation for ChromID followed by a Gram stain of characteristically colored colonies might represent the best compromise between sensitivity and specificity (sensitivity, 54.6%; specificity and PPV, 100%; NPV, 99%) (12) . Cost comparisons of ChromID and BEAV, when used in conjunction with broth enrichment, 24 hrs incubation, and Gram staining, showed that the numerous subcultures, supplementary identifications, susceptibility tests, and extra technician time required with BEAV actually allowed a saving of 0.62 € per sample with the use of ChromID for an annual GRE prevalence of 2.2% (12).
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MOLECULAR DIAGNOSTICS FOR MRSA (TABLE 3)
Since its discovery in the 1980s, the polymerase chain reaction (PCR) has become the cornerstone of molecular biology and currently available molecular diagnostic tests also rely heavily on this technology. for direct detection of MRSA carriage from nasal swabs and found the sensitivity of the former to be much higher (91.6% and 75%, respectively). NPVs were similar and high for both methods (99.5%), however, the PPV for the Hyplex StaphyloResist was only 31.4% (11) . Wagenvoort et al. showed that pooling specimens (nose, throat, perineum, wounds/infections) followed by an 18 hrs enrichment in a non-selective broth could increase the sensitivity (97.6%), and to some extent, the PPV (37.4%) of the Hyplex StaphyloResist, while still retaining a high specificity (83.7%) and NPV (99.7%) (41) This has been successfully utilized in commercial assays like the GenoType MRSA Direct, the IDI-MRSA, and the GeneXpert MRSA. The Genotype MRSA Direct targets SCCmec types I-V in a multiplex PCR using biotinylated primers followed by a reverse hybridization step. Direct detection of MRSA from nose, throat, groin, axilla, wound and other sites shows a high sensitivity, specificity, PPV and NPV (94.59%, 98.73%, 85.37%, 99.57 %, respectively) in comparison to culture (19) . An updated version of the assay, the Genoquick
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on October 22, 2017 by guest http://jcm.asm.org/ Downloaded from MRSA Dipstick assay does away with the reverse line hybridization step to reduce total assay time from 4 hrs to 2 hrs 20 min. The only study comparing the GenoQuick assay to the Genotype MRSA direct and to CHROMagar (BD Diagnostics) has demonstrated an impressive diagnostic sensitivity, specificity PPV, and NPV for the former assay (100%, 99.4%, 96%, 100 %, respectively) (16).
The IDI-MRSA (also called GeneOhm MRSA) is a multiplex qualitative real-time PCR assay and is a FDAapproved assay for the direct detection of nasal colonization by MRSA. This assay can be semi-automated using the SmartCycler instrument (Cepheid). The assay's most recent version (V3) contains primers targeting the right-junction sequences of SCCmec types I, II, III, IVa, b, c, and V, combined with one consensus primer and three molecular beacons specific for the orfX gene. This assay showed a sensitivity, specificity, PPV, and NPV of 98%, 96%, 77%, and 99.7%, respectively, for direct detection from nasal swabs (31) . Sensitivities and specificities for direct detection from throat and groin/perineum samples (89%, 99%; 88%, 99%, respectively) were also high (35) . Another study comparing IDI-MRSA to the Genotype MRSA and to three chromogenic media (MRSA-Select, ChromID, and CHROMagar) found IDI-MRSA to be the most rapid (2-3 hrs) and sensitive method independent of the sampling site (90% overall) although the assay's sensitivity declined from 94% with nasal swabs to 80% with swabs from other sites with groin swabs accounting for 75% of the missed samples (39) . While there is a general consensus for multiple body site screening to achieve optimal detection of MRSA carriers, the IDI-MRSA's price (USD 36.7/test) also necessitates pooling specimens. Bishop et al. showed comparable sensitivities and specificities for pooled nose-groin specimens to those processed separately with the IDI-MRSA (sensitivity, 90.0% for the nose, 83.3% for the groin, and 88.0% for the combined nose-groin specimen; specificity, 91.7%, 90.2%, and 91.6%, respectively) (4). Desjardins et al. assessed the utility of an overnight incubation of pooled nasal and rectal swabs in selective enrichment broth with aztreonam and ceftizoxime and showed a high sensitivity, specificity, NPV, and PPV (96%, 96%, 90%, and 98%, respectively) for the IDIMRSA assay in comparison to culture (13) . Rectal swabs are likely to
on October 22, 2017 by guest http://jcm.asm.org/ Downloaded from contain PCR inhibitors and pooling rectal and nasal specimens in broth decreases inhibition rate of the IDI-MRSA to < 1% (13) . The time lag in reporting of results due to an overnight enrichment step remains a major drawback, nonetheless, owing to the high sensitivity of PCR, a shorter (3-4 hrs) incubation time might be just as effective and warrants evaluation.
The GeneXpert MRSA is another FDA-approved real-time PCR assay and works on a fully automated GeneXpert platform. The assay proves expensive (USD 35-55) . However, total assay time is short (75 min.) and being fully automated, both the hands-on time (2 min.) and the level of expertise required for operation are minimal. A comparison of the GeneXpert and the IDI-MRSA showed similar sensitivities (98.5%; 97.1%, respectively) and specificities (90.4%; 89.2%, respectively) for MRSA detection from nasal samples (29) .
In order to highlight the impact of novel emerging SCCmec elements on the diagnostic accuracies of molecular assays targeting the orfX-SCCmec junction, Francois et al. evaluated the performance of the IDI-MRSA and Genotype MRSA Direct on well-characterized MRSA isolates from diverse genetic backgrounds (17) . The IDI-MRSA and Genotype MRSA Direct showed 94% and 90% sensitivities, however specificities were surprisingly low at 64% and 53%, respectively. While these assays fail to detect isolates harboring nontypeable or recently described SCCmec cassettes (variants of SCCmec IV and V) (17, 35) , high rates of false positive results could also be explained by the homology between the orfX moieties in S. aureus and other coagulase-negative species, such as S. haemolyticus or S. epidermidis, or with the capsular polysaccharide cluster, SCCcap1 that also has a similar integration site in the S. aureus genome as the SCCmec elements (27) . Furthermore, MSSA strains carrying a partially excised SCCmec and having lost the mecA gene can also give false-positive results on "single-locus" assays targeting the orfX-SCCmec junction. Hence, as new SCCmec variants emerge, iterative design modifications and revalidation of these assays is warranted.
MOLECULAR DIAGNOSTICS FOR GRE (TABLE 4)
Currently available molecular tests for GRE detection include the LightCycler vanA/B Detection assay (LC assay, Roche Diagnostics, Basel, Switzerland), and the GeneOhm VanR assay (BD Diagnostics-GeneOhm, San Diego, CA, USA).
The LC real-time PCR assay targets the vanA, vanB, and vanB-2/3 genes for direct detection of GRE from fecal or perianal swab samples, and time to detection, including nucleic acid extraction is 3.5 hrs. Sloan et al.. compared the LC assay to Enterococcosel agar for GRE detection from perianal swabs and the former assay detected twice the number of positive samples as the agar method (36) . A large number of these culturenegative samples were true-positives and represented vanB-harboring enterococci that might have been inhibited by the vancomycin incorporated in agar plates, or possibly even non-viable or noncultivable enterococci (36) . Because of the speed and ease of performance of the LC assay, it is conceivable that all patients could be screened for GRE before admission to healthcare institutions, including hospitals and nursing homes. However, it is important to note that the LC assay detects van genes rather than GRE per se. Thus, the presence of vanB in non-enterococcal species could result in an overestimation of the rate of fecal GRE colonization (15) , and decrease the specificity (30%-36%) of detection of vanB GRE in screening specimens by the LC assay (43) . A similar problem is observed with the GeneOhm VanR assay that also detects the vanA/B genes on a real time PCR. Direct detection of GRE from stool and rectal specimens shows a high sensitivity (96.6%), however specificity is decreased (87%) largely due to false positive results observed with the vanB part of the assay (37) . When used only to detect vanA resistance, the GeneOhm VanR assay was 94.4% sensitive and 96.4% specific, with a PPV and NPV of 91.3% and 97.7%, respectively (37) . Hence, both the LC and GeneOhm VanR assays can be used as GRE screening tests in populations that show a predominant colonization with vanA-harboring enterococci, while vanB positive samples need to be confirmed by another method for the presence of GRE. 
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CONCLUSIONS
Giant steps have been taken during the last decade to increase the diagnostic potential of the microbiology laboratory mainly by implementing methods for DNA and RNA amplification. PCR-based molecular diagnostics have not only allowed a clinically relevant turn-around time for a diagnostic result but also an increased sensitivity and specificity by linking it to an end-stage hybridization/ELISA or Real Time detection step. On the other hand, the high cost and relatively high operator skill requirement required for these tests are obstacles to their widespread routine use, and have led to the development of simpler culture-based albeit rapid detection methods. Several studies have analyzed and compared these detection methods, however, these studies differ significantly in the design, gold standards used, sampling sites, and enrichment protocols. Choice of gold standards especially bears a large influence on the study results. For instance, using an 'inferior' assay as a gold standard could (artificially) boost the performance results of the test method. Such factors should be taken into account before comparing study results. Our critical assessment of the existing literature identified several assays that perform well, however there is as yet no single, stand-alone rapid assay that can recover all MRSA or GRE strains. In addition, a need for even faster (and cheaper) diagnostic tests is being felt, highlighted by the mortality associated with MRSA/GRE infections, the ever-increasing problem of antimicrobial resistance, and the lack of new antibacterials in the pharmaceutical pipeline. Recognizing this need, the European Commission-funded project, MOSAR (Mastering hOSpital Antimicrobial Resistance and its spread into the community; https://www.mosar-sic.org/) brings together small biotechs and academic groups in order to achieve two major goals; i) to study the impact of rapid diagnostic interventions on MRSA/GRE colonization and infection rates in hospitals and, ii) to apply cutting edge technological advances for the development of next-generation, rapid diagnostic assays for MRSA and GRE detection. Table 4 A C C E P T E D
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